Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

BUY
$0.58 - $1.3 $9,706 - $21,755
16,735 New
16,735 $17,000
Q3 2022

Nov 09, 2022

SELL
$1.7 - $4.05 $1,749 - $4,167
-1,029 Reduced 8.39%
11,231 $31,000
Q2 2022

Aug 10, 2022

BUY
$1.6 - $5.07 $217 - $689
136 Added 1.12%
12,260 $23,000
Q1 2022

May 12, 2022

SELL
$3.92 - $5.86 $5,292 - $7,911
-1,350 Reduced 10.02%
12,124 $48,000
Q4 2021

Feb 10, 2022

SELL
$5.0 - $14.85 $35,475 - $105,360
-7,095 Reduced 34.49%
13,474 $71,000
Q3 2021

Nov 12, 2021

BUY
$12.13 - $16.99 $249,501 - $349,467
20,569 New
20,569 $285,000

Others Institutions Holding AMRS

About AMYRIS, INC.


  • Ticker AMRS
  • Exchange NASDAQ
  • Sector Basic Materials
  • Industry Specialty Chemicals
  • Shares Outstandng 324,860,000
  • Market Cap $3.25M
  • Description
  • Amyris, Inc., a synthetic biotechnology company, operates in the clean health and beauty, and flavors and fragrance markets in Europe, North America, Asia, and South America. The company manufactures and sells clean beauty, personal care, and health and wellness consumer products, as well as ingredients to the flavor and fragrance, nutrition, fo...
More about AMRS
Track This Portfolio

Track High Tower Advisors, LLC Portfolio

Follow High Tower Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Tower Advisors, LLC with notifications on news.